Company Name: Ritter Pharmaceuticals Inc.
Ritter Pharmaceuticals Inc. is a developer of therapeutics that are designed to modulate the human gut microbiome for the treatment of gastrointestinal diseases. The company’s initial product candidate is designed to treat lactose intolerance.
Ticker Symbol: RTTR (NASDAQ)
Company Website: www.ritterpharmaceuticals.com
Headquarters: Los Angeles, CA